Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for Mirum Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (MIRM).
- Disclosed ownership: 3%.
- Date of event: 30 Sep 2025.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 3% ownership in Mirum Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (MIRM) on 30 Sep 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 1.5% | 772,595 | 0 | 772,595 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 1.5% | 772,595 | 0 | 772,595 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 1.2% | 610,666 | 0 | 610,666 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 1.2% | 610,666 | 0 | 610,666 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.2% | 82,238 | 0 | 82,238 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.2% | 82,238 | 0 | 82,238 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 2.8% | 1,383,261 | 0 | 1,383,261 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 3% | 1,495,290 | 0 | 1,495,290 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 3% | 1,495,290 | 0 | 1,495,290 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 3% | 1,495,290 | 0 | 1,495,290 | /s/ Mark N. Lampert | Mark N. Lampert |